solaraze3 - søkeresultat

USA - engelsk - NLM (National Library of Medicine)

solaraze- diclofenac sodium gel

pharmaderm a division of fougera pharmaceuticals inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - solaraze® (diclofenac sodium) gel is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. solaraze® (diclofenac sodium) gel is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol, polyethylene glycol monomethyl ether 350 and/or hyaluronate sodium. solaraze® (diclofenac sodium) gel is contraindicated in the following patients: - in the setting of coronary artery bypass graft (cabg) surgery.

USA - engelsk - NLM (National Library of Medicine)

solaraze- diclofenac sodium gel

pharmaderm a division of fougera pharmaceuticals inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - solaraze® (diclofenac sodium) gel is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. solaraze® (diclofenac sodium) gel is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol, polyethylene glycol monomethyl ether 350 and/or hyaluronate sodium. solaraze® (diclofenac sodium) gel is contraindicated in the following patients: - in the setting of coronary artery bypass graft (cabg) surgery.

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

solaraze 30 mg/g gel

almirall s.a. - diclofenaco sodico - gel - 30 mg/g - diclofenaco sodico 30 mg - diclofenaco

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

solaraze diclofenac sodium 3 % gel tube

mayne pharma international pty ltd - diclofenac sodium, quantity: 3 % w/w - gel - excipient ingredients: polyethylene glycol monomethyl ether; benzyl alcohol; sodium hyaluronate; purified water - management of actinic keratosis.